EUCTR2006-005715-10-GB
Active, not recruiting
Not Applicable
The Control of Hyperglycaemia In Paediatric intensive care (The CHIP Trial). - The CHIP Trial
Royal Brompton & Harefield NHS Trust0 sites1,500 target enrollmentMarch 12, 2007
DrugsActrapid 100 IU/ml
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Royal Brompton & Harefield NHS Trust
- Enrollment
- 1500
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children from birth to \<16 years who are undergoing intensive care treatment with an arterial line in\-situ and receiving both mechanical ventilation and vasoactive support drugs following injury, major surgery or in association with critical illness in whom it is anticipated such treatment will be required to continue for at least 12 hours.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Children born pre\-term and who are \< 36 weeks corrected gestation
- •Children with diabetes mellitus
- •Children with an established or suspected diagnosis of an inborn error of metabolism
- •Children for whom treatment withdrawal or limitation of intensive care treatment is being considered
- •Children who have been in a PICU for more than 5 days in succession
- •Children admitted to a PICU who have already participated in the CHIP study during a previous PICU admission.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Control of hyperglycaemia in paediatric intensive careHyperglycaemiaSigns and SymptomsElevated blood glucose levelISRCTN61735247Royal Brompton & Harefiled NHS Trust (UK)1,500
Not yet recruiting
Not Applicable
Optimising glycaemic control in paediatric patients on insulin pump therapy: impact of glycaemic load and bolus wave type on postprandial glycaemiaType 1 Diabetes MellitusMetabolic and Endocrine - DiabetesACTRN12605000762651Royal Children's Hospital, Parkville, Vic 3052.36
Completed
Not Applicable
Effective treatment of hypoglycaemia in children with type 1 diabetes: A randomised controlled clinical trialHypoglycaemiaMetabolic and Endocrine - DiabetesACTRN12609000129280Esko Wiltshire160
Recruiting
Not Applicable
Insulin therapy in critically ill children with hyperglycemia: clinical and biochemical characteristics.Hyperglycemia, insulin sensitivity , critical illness, child, PICUHyperglycemie, insuline gevoeligheid, ernstige ziekte, kind, PICNL-OMON27655ErasmusMC Rotterdam, Sophia Childrens Hospital60
Completed
Not Applicable
Clinical factors of hyperglycemia in children after surgery for congenital heart disease and thier prognosisCongenital heart diseases which underwent open heart surgeryJPRN-UMIN000021214Department of Anaesthesiology and Intensive Care Unit, Yokohama City University Hospital100